全文获取类型
收费全文 | 1736篇 |
免费 | 103篇 |
国内免费 | 21篇 |
专业分类
儿科学 | 12篇 |
妇产科学 | 14篇 |
基础医学 | 64篇 |
口腔科学 | 17篇 |
临床医学 | 309篇 |
内科学 | 160篇 |
皮肤病学 | 11篇 |
神经病学 | 57篇 |
特种医学 | 11篇 |
外科学 | 129篇 |
综合类 | 340篇 |
预防医学 | 330篇 |
眼科学 | 2篇 |
药学 | 204篇 |
2篇 | |
中国医学 | 37篇 |
肿瘤学 | 161篇 |
出版年
2024年 | 8篇 |
2023年 | 26篇 |
2022年 | 63篇 |
2021年 | 80篇 |
2020年 | 88篇 |
2019年 | 47篇 |
2018年 | 62篇 |
2017年 | 69篇 |
2016年 | 79篇 |
2015年 | 61篇 |
2014年 | 200篇 |
2013年 | 188篇 |
2012年 | 183篇 |
2011年 | 190篇 |
2010年 | 125篇 |
2009年 | 77篇 |
2008年 | 68篇 |
2007年 | 52篇 |
2006年 | 46篇 |
2005年 | 24篇 |
2004年 | 16篇 |
2003年 | 19篇 |
2002年 | 14篇 |
2001年 | 10篇 |
2000年 | 11篇 |
1999年 | 8篇 |
1998年 | 1篇 |
1997年 | 4篇 |
1996年 | 1篇 |
1995年 | 4篇 |
1994年 | 1篇 |
1993年 | 5篇 |
1992年 | 1篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1978年 | 1篇 |
1975年 | 1篇 |
1973年 | 3篇 |
排序方式: 共有1860条查询结果,搜索用时 15 毫秒
1.
经济社会的快速发展,提升了人们的生活水平人们对医疗事业的发展提出了更高的要求,我国也加大了对医疗事业的建设与发展。尤其是所使用的相关设备与仪器。其中,医用B超就是最主要的医疗设备,能够通过设备的检查,对人体的身体情况以数据的形式展现,直接能够了解到人体的健康情况,提升医疗事业的技术水平,同时,也为医疗工作这提供了方便快捷的工作方式。但是,医用B超设备在使用的过程中,会受到一些因素的影响,使其发生故障,会对各项工作造成不同程度的影响。因此,需要对其加强管理,能够及时地发现故障问题,采取科学的措施解决,确保医疗事业的稳定发展。 相似文献
2.
目的:探究金水宝片联合依诺肝素对维持性血液透析患者血脂代谢的影响。方法:选取2018年12月至2019年3月马鞍山十七冶医院血液净化中心进行透析的患者154例作为研究对象,根据用药不同分为对照组和观察组,每组77例。对照组常规应用依诺肝素抗凝,观察组在对照组抗凝基础上加用金水宝片,各组均干预3个月,比较2组患者血脂变化及持续血液透析并发症发生情况。结果:治疗后,观察组患者三酰甘油、总胆固醇及低密度脂蛋白胆固醇水平下降,高密度脂蛋白胆固醇升高,与治疗前比较差异均有统计学意义(P<0.05),与对照组治疗后比较,差异有统计学意义(P<0.05);观察组总并发症发生率明显低于对照组,2组比较差异有统计学意义(P<0.05);2组患者维持性血液透析不良反应发生率均较低,组间比较差异无统计学意义(P>0.05)。结论:金水宝片联合依诺肝素有助于改善维持性血液透析患者血脂代谢水平,降低维持性血液透析相关并发症,值得临床推广应用。 相似文献
3.
4.
护理人员的职业损伤因素及健康维护 总被引:27,自引:0,他引:27
作者指出临床一线的护理人员是发生职业损伤的高危群体。产生职业损伤的危险因素包括基础教育和继续教育缺乏职业损伤及其防范知识;影响护理人员身体健康的诸因素,如化疗专用的溶药设备、洁净操作台或相对密闭的溶药环境不健全;乙型肝炎等医院内易感性等疾病增加,被血液、体液等污染的医疗锐器刺伤是护理人员职业感染的主要途径;护理人员工作职业特点对健康不利的影响,护理人员心理压力大。为维护护理人员身心健康,应加入医院感染、职业损伤和健康维护的在校理论教育内容,加强护理人员职业安全教育,采取防范职业损伤的措施,如化疗药物中心配药、使用一次性手套等措施。 相似文献
5.
Steven R. Alexander Gerald S. Arbus Khalid M. H. Butt Susan Conley Richard N. Fine Ira Greifer Alan B. Gruskin William E. Harmon Paul T. McEnery Thomas E. Nevins Nadia Nogueira Oscar Salvatierra Jr Amir Tejani 《Pediatric nephrology (Berlin, Germany)》1990,4(5):542-553
This report of the North American Pediatric Transplant Cooperative Study summarizes data contributed by 57 participating centers on 754 children with 761 transplants from 1 January 1989 to 16 February 1989. Data collection was initiated in October 1987 and follow-up of all patients is ongoing. Transplant frequency increased with age; 24% of the patients were less than 5 years, with 7% being under 2 years. Common frequent diagnoses were: aplastic/dysplastic kidneys (18%), obstructive uropathy (16%), and focal segmental glomerulosclerosis (12%). Preemptive transplant, i.e., transplantation without prior maintenance dialysis, was performed in 21% of the patients. Dialytic modalities pretransplant were peritoneal dialysis in 42% and hemodialysis in 25%. Bilateral nephrectomy was reported in 29%. Live-donor sources accounted for 42% of the transplants. Among cadaveric donors, 41% of the donors were under 11 years old. During the first post-transplant month, maintenance therapy was used similarly for live-donor and cadaver source transplants, with prednisone, cyclosporine, and azathioprine used in 93%, 83%, and 81%, respectively. Triple therapy with prednisone, cyclosporine, and azathioprine was used in 78%, 75%, and 75% of functioning cadaver source transplants at 6 months, 12 months, and 18 months as opposed to 60%, 63%, and 54% for live-donor procedures, with single-drug therapy being uncommon. Rehospitalization during months 1–5 occurred in 62% of the patients, with treatment of rejection and infection being the main causes. Additionally, 9% were hospitalized for hypertension. During months 6–12 and 12–17, 30% and 28% of the patients with functioning grafts were rehospitalized. Times to first rejection differed significantly for cadaver and live-donor transplants. The median time to the first rejection was 36 days for cadaver transplants and 156 days for live-donor transplants. Overall, 57% of treated rejections were completely reversible although the complete reversal rate decreased to 37% for four or more rejections. One hundred and fifty-two graft failures had occurred at the time of writing, with a 1-year graft survival estimate of 0.88 for live-donor and 0.71 for cadaver source transplants. In addition to donor source, recipient age is a significant prognostic factor for graft survival. Among cadaver donors, decreasing donor age is associated with a decreasing probability of graft survival. Thirty-five deaths have occurred; 16 attributed to infection and 19 to other causes. The current 1-year survival estimate is 0.94. There have been 9 malignancies.A list of all participating centers and the names of the investigators is printed on pages 552–553 相似文献
6.
7.
终末期肾衰维持性血透死亡70例临床分析 总被引:14,自引:0,他引:14
目的 探讨终末期肾衰(ESRF)在维持性血液透析(MHD)中的死因及离治对策。方法 对70例在MHD中死亡的ESRF者主要并发症及死因作回顾性分析。结果 近13年来MHD的ESRF患者死亡70例,平均 透析54.7周,93.8次。原发病以慢性肾小球肾炎为主(71.4%)。MHD之前已有高血压,且每次血透前、后伴发高血压次数超过其血透总次数的30%者47例。死因:脑出血27例,心衰23例,心率失常6例,消化道大出血4例,心肌梗死3例,肺结核1例。其中多囊肾中3例(3/4)、痛风性肾病3例(3/3)、高血压肾病中2例(2/3)均死于脑出血。结论 ESRF在MHD中主要死因是脑出血和心衰,高血压是主要危险因素应予良好控制。多囊肾和痛风引起的ESRF在MHD中易因脑出血而死亡。 相似文献
8.
Summary A total of 20 children with various types of epilepsy were treated with valproate, 11 with monotherapy and 9 with valproate in combination with phenobarbitone, phenytoin, or carbamazepine. Valproate was given either every 8 or 12 h. At least two different dose levels were tried in each patient. The pharmacokinetics of valproate during the interval between doses was determined using a gas chromatographic technique. The clinical effect of the treatment was assessed by interviewing the parents.The plasma concentrations showed considerable fluctuation during the intervals between doses. The mean increase from pre-administration to peak level was 82% when the dose interval was 12 h, and 62% when it was 8 h. The mean plasma half-life of valproate, using a one-compartment model, was 10.9±1.3 h (mean±SD). The plasma half-life of valproate was decreased when the drug was combined with the other anti-epileptics. The calculated area under the concentration versus time curve was linearly related to dose, both in a single patient on four dose levels and when different patients were compared. The clinical effect of valproate monotherapy was best in patients with absences, usually good in myoclonus and less favourable in other types of epilepsy. For children with absences, the optimal dose range of valproate was between 20 and 40 mg/kg/24 h. In comparison, the myoclonic types of epilepsy needed a slightly higher dose level, between 30 and 60 mg/kg/24 h. In the latter group a therapeutic window seems to exist, since patients below and above the suggested dose levels were not well-controlled. Therapeutic monitoring of valproate does not appear meaningful when the drug is used as monotherapy. However, in combination therapy, determination of the plasma levels of all anti-convulsants used may be helpful. The large fluctuations of valproate during a dose interval must be taken into consideration when the clinical effects are analysed.Supported by the Swedish Medical Research Council (Project No. 522), Stiftelsen Margarethahemmet, and Sällskapet Barnavård 相似文献
9.
随着医疗卫生事业的飞速发展,大量高科技电子设备不断涌现,是技术密集.知识密集、资金密集的产品,而血液透析机无论是国产还是进口的设备,(进口占比侧大),均属高科技机电一体化医电产品,并且采用微机技术.自检报警功能多,操作相对复杂,而不同产地(不同型号其操作方法和日常维护方法也不同着重阐述了透析机供电和透析掖的配制和血液透析机的维护与保养和维修。 相似文献
10.
维持性血液透析患者住院的相关因素分析 总被引:2,自引:0,他引:2
目的探讨维持性血液透析患者住院的相关因素。方法对我院82例维持性血液透析患者进行回顾性分析,对住院和非住院的维持性血透患者的血清白蛋白、血红蛋白、血肌酐、血尿素氮等生化指标和平均动脉压、透析时间、每日残余尿量、促红素用量及降压药物的使用等临床指标进行比较;利用单因素分析探讨维持性血液透析患者住院的危险因素。结果两组患者间年龄、性别、透析时间、每日残余尿量、血肌酐、血尿素氮水平、促红素用量及降压药物的使用方面均无统计学差异;血清白蛋白、血红蛋白、平均动脉压在两组之间存在有显著统计学差异(P<0.01)。单因素分析结果显示,低血清白蛋白、低血红蛋白、血压控制不良与维持性血液透析患者住院有关(P<0.001)。结论低血清白蛋白、贫血、血压控制不良为维持性血液透析患者住院的危险因素。 相似文献